The mission of this blog is to provide unique insights on patent law developments in at least the BRIC countries – Brazil, Russia, India and China. We say “at least” because we intend to expand our discussions to other emerging market countries such as South Africa, Vietnam, South Korea, Singapore, Philippines, etc. Our emphasis will be primarily in the chemical and life sciences areas. From time-to-time, patent attorneys from these countries will provide guest posts to share their perspective and unique experiences.
The BRIC Wall will comment on the latest law changes in these countries and provide insights and practical suggestions to help patent attorneys and agents, business people and others achieve the best possible patent strategy in these countries.
We want to start a conversation with those of you that have filed and prosecuted patent applications, sought regulatory approval and/or litigated cases in these countries to share your experiences – including any successes and failures. You are invited to comment on our postings and encouraged to ask questions.
Michael Best’s Life Sciences Team serves the diverse needs of the biotechnology, pharmaceutical, chemical and medical device industries. We assist our clients in achieving their business goals and objectives by providing broad, cost-effective intellectual property counseling and portfolio management services. Our attorneys have extensive experience acquiring and enforcing patent rights worldwide; counseling and negotiating a broad variety of collaborative research, development, licensing and marketing arrangements and technology transfers; assessing value and risks associated with proprietary technology such as performing due diligence, patent validity, infringement and freedom-to-operate analyses and advising on litigation and other inter partes matters.
Our Life Sciences attorneys and professionals are knowledgeable in all aspects of the life sciences spectrum – our team includes approximately twenty patent prosecutors, most of whom hold advanced degrees. Specific technologies include drug discovery and delivery, therapeutic molecules and medical treatments, biomolecular assays and screening, diagnostics and research tools, gene therapy, bioinformatics, proteomics, genomics, glycobiology, immunology, virology, tissue engineering, transgenic plants and animals, physical sciences, polymer chemistry, specialty chemicals, food and beverage science, bionanotechnology, imaging devices and medical devices. Such experience, combined with our broad licensing and litigation experience, is invaluable in obtaining patents that can be effectively licensed or enforced against infringers.
Our clients range from universities and research institutes to emerging and venture capital companies to global market leaders. We work closely with our clients’ in-house innovators and management to craft winning strategies to advance our clients’ objectives and maximize patent value.
Michael Best is the exclusive member firm for Wisconsin of Lex Mundi, the world’s leading association of independent law firms. Member firms are present in more than 160 countries, states and provinces, covering virtually every business market worldwide. Our firm’s membership in Lex Mundi provides us with global reach and access to unparalleled legal resources that enhance our ability to serve our clients’ needs seamlessly around the world.
Disclaimer: The information provided herein is intended only as general information which may or may not reflect the most current legal developments. This communication should not be construed as legal advice or an opinion on specific situations. © 2016 Michael Best & Friedrich LLP. All rights reserved